These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7488074)

  • 1. Differential activation of PKC isozymes by 14-3-3 zeta protein.
    Acs P; Szallasi Z; Kazanietz MG; Blumberg PM
    Biochem Biophys Res Commun; 1995 Nov; 216(1):103-9. PubMed ID: 7488074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKC-delta and -epsilon regulate NF-kappaB activation induced by cholecystokinin and TNF-alpha in pancreatic acinar cells.
    Satoh A; Gukovskaya AS; Nieto JM; Cheng JH; Gukovsky I; Reeve JR; Shimosegawa T; Pandol SJ
    Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G582-91. PubMed ID: 15117677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological regulation of network kinetics by protein kinase C localization.
    Mochly-Rosen D; Kauvar LM
    Semin Immunol; 2000 Feb; 12(1):55-61. PubMed ID: 10723798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol sulfate activates multiple protein kinase C isoenzymes and induces granular cell differentiation in cultured murine keratinocytes.
    Denning MF; Kazanietz MG; Blumberg PM; Yuspa SH
    Cell Growth Differ; 1995 Dec; 6(12):1619-26. PubMed ID: 9019167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms.
    van der Merwe JQ; Moreau F; MacNaughton WK
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1258-66. PubMed ID: 19359428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C activation by acidic proteins including 14-3-3.
    Van Der Hoeven PC; Van Der Wal JC; Ruurs P; Van Blitterswijk WJ
    Biochem J; 2000 May; 347 Pt 3(Pt 3):781-5. PubMed ID: 10769183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C activators as synaptogenic and memory therapeutics.
    Sun MK; Alkon DL
    Arch Pharm (Weinheim); 2009 Dec; 342(12):689-98. PubMed ID: 19899099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anchoring proteins for protein kinase C: a means for isozyme selectivity.
    Mochly-Rosen D; Gordon AS
    FASEB J; 1998 Jan; 12(1):35-42. PubMed ID: 9438408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes.
    van Eis MJ; Evenou JP; Floersheim P; Gaul C; Cowan-Jacob SW; Monovich L; Rummel G; Schuler W; Stark W; Strauss A; von Matt A; Vangrevelinghe E; Wagner J; Soldermann N
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7367-72. PubMed ID: 22078216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes.
    Gschwendt M; Dieterich S; Rennecke J; Kittstein W; Mueller HJ; Johannes FJ
    FEBS Lett; 1996 Aug; 392(2):77-80. PubMed ID: 8772178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKC isozyme S-cysteinylation by cystine stimulates the pro-apoptotic isozyme PKC delta and inactivates the oncogenic isozyme PKC epsilon.
    Chu F; Ward NE; O'Brian CA
    Carcinogenesis; 2003 Feb; 24(2):317-25. PubMed ID: 12584183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexins - scaffolds modulating PKC localization and signaling.
    Hoque M; Rentero C; Cairns R; Tebar F; Enrich C; Grewal T
    Cell Signal; 2014 Jun; 26(6):1213-25. PubMed ID: 24582587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic modulation of protein kinase C isozymes: the role of RACKs and subcellular localisation.
    Csukai M; Mochly-Rosen D
    Pharmacol Res; 1999 Apr; 39(4):253-9. PubMed ID: 10208754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976.
    Martiny-Baron G; Kazanietz MG; Mischak H; Blumberg PM; Kochs G; Hug H; Marmé D; Schächtele C
    J Biol Chem; 1993 May; 268(13):9194-7. PubMed ID: 8486620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isozyme-specific inhibitors and activators of protein kinase C.
    Schechtman D; Mochly-Rosen D
    Methods Enzymol; 2002; 345():470-89. PubMed ID: 11665630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the alpha, beta II, and gamma protein kinase C isozymes in the baculovirus-insect cell expression system. Purification and characterization of the individual isoforms.
    Burns DJ; Bloomenthal J; Lee MH; Bell RM
    J Biol Chem; 1990 Jul; 265(20):12044-51. PubMed ID: 2195030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the protein kinase C family: are we there yet?
    Mackay HJ; Twelves CJ
    Nat Rev Cancer; 2007 Jul; 7(7):554-62. PubMed ID: 17585335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKC isozymes in chronic cardiac disease: possible therapeutic targets?
    Churchill E; Budas G; Vallentin A; Koyanagi T; Mochly-Rosen D
    Annu Rev Pharmacol Toxicol; 2008; 48():569-99. PubMed ID: 17919087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of lead on PKC isoforms.
    Coppi AA; Lesniak J; Zieba D; Schanne FA
    Ann N Y Acad Sci; 2000; 919():304-6. PubMed ID: 11083121
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure.
    Sabri A; Steinberg SF
    Mol Cell Biochem; 2003 Sep; 251(1-2):97-101. PubMed ID: 14575310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.